Trails Edge Biotechnology Offshore Fund, LP updates its Form D — $292.9M sold

Fund raise update · Hedge fund · Open-ended · ATLANTA, GA · Form D/A filed 2026-06-25 · all Trails Edge Biotechnology vehicles

$100M+ sold3(c)(7) — qualified purchasers

Why now — by persona

Relevant to: Fund audit & tax, Fund administrator. Lead card pending.

- Trails Edge Biotechnology Fund GP, LP	General Partner
- Trails Edge Capital Partners, LP	Investment Manager
Ortav Yehudai	Executive Officer
Matthew Diaz	Executive Officer

Signed by Matthew Diaz, CFO/COO/CCO.

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

New fund · Hedge fund · Pre-first close · Offering Indefinite · ATLANTA, GA · filed 2025-06-25

3(c)(7) — qualified purchasersPre-first closeFirst filing by this entity